Abstract
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are potentially life-threatening, immune-mediated adverse reactions characterized by widespread erythema, epidermal necrosis, and detachment of skin and mucosa. Efforts to grow and develop functional international collaborations and a multidisciplinary interactive network focusing on SJS/TEN as an uncommon but high burden disease will be necessary to improve efforts in prevention, early diagnosis and improved acute and long-term management. SJS/TEN 2019: From Science to Translation was a 1.5-day scientific program held April 26–27, 2019, in Vancouver, Canada. The meeting successfully engaged clinicians, researchers, and patients and conducted many productive discussions on research and patient care needs.
| Original language | English |
|---|---|
| Pages (from-to) | 2-12 |
| Number of pages | 11 |
| Journal | Journal of Dermatological Science |
| Volume | 98 |
| Issue number | 1 |
| DOIs | |
| State | Published - 04 2020 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2020
Keywords
- Human leukocyte antigen (HLA)
- Pharmacogenomics
- Pharmacovigilance
- Severe cutaneous adverse reaction (SCAR)
- Stevens-Johnson syndrome (SJS)
- Toxic epidermal necrolysis (TEN)